Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.65 |
| ▸ | HPGD | P15428 | 6/20 | 0.65 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA4 | P22748 | 2/20 | 0.65 |
| ▸ | CA5A | P35218 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | CA3 | P07451 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CA6 | P23280 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 1/20 | 0.65 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 4/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | ALPL | P05186 | 9/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669657 | 0.89 | KDM4E (0.77) | KDM4EALDH1A1HPGDCA12CA1 | |
| SCHEMBL3265953 | 0.88 | KDM4E (0.62) | KDM4EALDH1A1HPGDCA12CA1 | |
| SCHEMBL4104045 | 0.79 | KDM4E (0.65) | KDM4EALDH1A1HPGDCA12CA1 | |
| Coumaphos SCHEMBL29363459 | 0.79 | KDM4E (1.00) | KDM4EALDH1A1HPGDCA12CA1 | |
| Coumaphos SCHEMBL9283960 | 0.79 | KDM4E (1.00) | KDM4EALDH1A1HPGDCA12CA1 | |
| Coumaphos SCHEMBL120173 | 0.79 | KDM4E (1.00) | KDM4EALDH1A1HPGDCA12CA1 | |
| SCHEMBL38663564 | 0.78 | KDM4E (0.70) | KDM4EALDH1A1HPGDCA12CA1 | |
| SCHEMBL4104048 | 0.78 | KDM4E (0.70) | KDM4EALDH1A1HPGDCA12CA1 | |
| SCHEMBL6150849 | 0.77 | KDM4E (0.69) | KDM4EALDH1A1HPGDCA12CA1 | |
| Coumaphos SCHEMBL9812694 | 0.77 | KDM4E (0.89) | KDM4EALDH1A1HPGDCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1792 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2024059837-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | IN THE BOWL ANIMAL HEALTH, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| WO-2023126969-A1 | ORAL FILMS OF ANIT-PARASITIC DRUGS | LAURUS LABS LIMITED (IN) | 2023-07-06 | — | — | WO | claimed |
| CN-111972277-B | Method for breeding black wheat germplasm with different genetic backgrounds by utilizing blue dwarf male sterile and purple wheat | 淄博爱民种业有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-111972277-A | Method for breeding black wheat germplasm with different genetic backgrounds by utilizing blue dwarf male sterile and purple wheat | 淄博爱民种业有限公司 | 2020-11-24 | — | — | CN | claimed |
| EP-1675474-B9 | PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION | NOVARTIS TIERGESUNDHEIT AG (CH) | 2018-12-05 | — | — | EP | claimed |
| EP-1675474-B2 | PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION | NOVARTIS TIERGESUNDHEIT AG (CH) | 2016-12-07 | — | — | EP | claimed |
| US-9345108-B2 | Self-adaptive brightness sensor light, brightness sensor module, and brightness-adjusting method of the same | IR-TEC INTERNATIONAL LTD. (TW) | 2016-05-17 | — | — | US | claimed |
| US-20150216015-A1 | SELF-ADAPTIVE BRIGHTNESS SENSOR LIGHT, BRIGHTNESS SENSOR MODULE, AND BRIGHTNESS-ADJUSTING METHOD OF THE SAME | IR-TEC INTERNATIONAL LTD. (TW) | 2015-07-30 | — | — | US | claimed |
| WO-2015089530-A1 | EXTENDED-RELEASE ORAL DOSAGE FORM CONTAINING MORPHINE AND NALOXONE | G.L. PHARMA GmbH (AT) | 2015-06-25 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| JP-2007500004-A | — | — | 2007-01-11 | — | — | JP | claimed |
| US-20060257966-A1 | Medium for detection and identification of micro-organisms | BIOMERIEUX (FR) | 2006-11-16 | — | — | US | claimed |
| US-20060222684-A1 | Palatable ductile chewable veterinary composition | ELANCO TIERGESUNDHEIT AG (CH) | 2006-10-05 | — | — | US | claimed |
| CN-1829448-A | Palatable ductile chewable veterinary composition | NOVARTIS AG (CH) | 2006-09-06 | — | — | CN | claimed |
| EP-1675474-A1 | PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION | Novartis AG (CH) | 2006-07-05 | — | — | EP | claimed |
| CN-1583174-A | Long-term injection containing ethylcellulose and fatty acid ester | WANG YUWAN (CN) | 2005-02-23 | — | — | CN | claimed |
| WO-2005013714-A1 | PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | claimed |
| CN-1444925-A | Long acting injection containing ethyl cellulose for animal | WANG YUWAN (CN) | 2003-10-01 | — | — | CN | claimed |
| EP-0651055-A2 | Uses of modified cholinesterase and compositions containing them | State of Israel Represented by the Prime Minister's Office The Israel Institute for Biological Research (IL) | 1995-05-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222684-A1 | Palatable ductile chewable veterinary composition | PIGO, TAS2R41, TAS2R30 | KDM4E 3180/4885ALDH1A1 3866/4885HPGD 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.